Cytoskeletal regulation of the L-arginine/no pathway in pulmonary artery endothelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 3 24-3, 2001, Pages

  Zharikov, Sergey I ^a   Sigova, Alla A ^a   Chen, Sifeng ^a   Bubb, Michael R ^b   Block, Edward R ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Actin cytoskeleton; Jasplakinolide; L arginine transporter; Nitric oxide production; Pulmonary endothelial cells; Swinholide

Indexed keywords

ARGININE; FLUORESCEIN DIACETATE; JASPAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SWINHOLIDE A;

ACTIN FILAMENT; ACTIN POLYMERIZATION; AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; MICROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; REGULATORY MECHANISM;

EID: 0035000923     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.3.l465     Document Type: Article

References (58)

1. Aisaka K, Gross S, Griffith OW, and Levi R. L-Arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem Biophys Res Commun 163: 710-717, 1989.
2. Anderson RGW. The caveolae membrane system. Annu Rev Biochem 67: 199-225, 1998.
3. Beck KA and Nelson WJ. The spectrin-based membrane skeleton as a membrane protein-sorting machine. Am J Physiol Cell Physiol 270: C1263-C1270, 1996.
4. Block ER, Herrera H, and Couch M. Hypoxia inhibits L-arginine uptake by pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 269: L574-L580, 1995.
5. Bogle RG, Coade SB, Moncada S, Pearson JD, and Mann GE. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun 180: 926-932, 1991.
6. Bubb MR, Senderowicz AMJ, Sausville EA, Duncan KLK, and Korn ED. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem 269: 14869-14871, 1994.
7. Bubb MR, Spector I, Bershadsky AD, and Korn ED. Swinholide is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments. J Biol Chem 270: 3463-3466, 1995.
8. Bubb MR, Spector I, Beyer BB, and Fosen KM. Effects of jasplakinoloide on the kinetics of actin polymerization. An explanation for certain in vivo observations. J Biol Chem 275: 5163-5170, 2000.
9. Bussolati O, Laris PC, Nucci FA, Dall'Asta V, Longo N, Guidotti GG, and Gazzola GC. Dependence of L-arginine accumulation on membrane potential in cultured human fibroblasts. Am J Physiol Cell Physiol 253: C391-C397, 1987.
10. +-ATPase. Am J Physiol Renal Fluid Electrolyte Physiol 269: F637-F643, 1995.
11. + channel activity. Am J Physiol Cell Physiol 261: C882-C888, 1991.
12. Closs EI. CATs, a family of three distinct mammalian cationic amino acid transporters. Amino Acids (Vienna) 11: 193-208, 1996.
13. Closs EI, Scheld J-S, Sharafi M, and Forstermann U. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol 57: 68-74, 2000.
14. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, and Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 83: 1057-1062, 1991.
15. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, and Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90: 1248-1253, 1992.
16. Davda RK, Chandler LJ, Crews FT, and Guzman NJ. Ethanol enhances the endothelial nitric oxide synthase response to agonists. Hypertension 21: 939-943, 1993.
17. Deves R and Boyd CAR. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78: 487-545, 1998.
18. Feron O, Saldana F, Michel JB, and Michel T. The eNOScaveolin regulatory cycle. J Biol Chem 273: 3125-3128, 1998.
19. Fujimoto T, Miyawaki A, and Mikoshiba K. Inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae is linked to actin filaments. J Cell Sci 108: 7-15, 1996.
20. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, and Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implication for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996.
21. Gottlieb AI, Langille BL, Wong MKK, and Kim DW. Structure and function of the endothelial cytoskeleton. Lab Invest 65: 123-137, 1991.
22. Green B, Pacitti AJ, and Souba WW. Characterization of L-arginine transport by pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 264: L351-L356, 1993.
23. Hutcheson IR and Griffith TM. Mechanotransduction through the endothelial cytoskeleton: mediation of flow-but not agonist-induced EDRF release. Br J Pharmacol 118: 720-726, 1996.
24. Kavanaugh MP. Voltage dependence of facilitated arginine flux mediated by the system y+ basic amino acid transporter. Biochemistry 32: 5781-5785, 1993.
25. Knudsen HL and Frangos JA. Role of cytoskeleton in shear stress-induced endothelial nitric oxide production. Am J Physiol Heart Circ Physiol 273: H347-H355, 1997.
26. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70: 2446-2453, 1998.
27. Kurz S and Harrison DG. Insulin and the arginine paradox. J Clin Invest 99: 369-370, 1997.
28. Lisanti MP, Scherer PE, Tang Z, and Sargaicomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 4: 231-235, 1994.
29. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, and Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126: 111-126, 1994.
30. Liu. J, Garcia-Cardena G, and Sessa WC. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35: 13277-13281, 1996.
31. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
32. - secretion and Na-K-2Cl cotransport. Am J Physiol Cell Physiol 272: C254-C262, 1997.
33. McDonald KK, Zharikov S, Block ER, and Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric oxide synthase may explain the "arginine paradox". J Biol Chem 272: 31213-31216, 1997.
34. Mills JW and Mandel LJ. Cytoskeletal regulation of membrane transport events. FASEB J 8: 1161-1165, 1994.
35. Mombouli J and Vanhoutte P. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol 35: 679-705, 1995.
36. Moncada S, Palmer R, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
37. Nakatsubo N, Kojima H, Kikuchi K, Nagoshi H, Hirata Y, Maeda D, Imai Y, Irimura T, and Nagano T. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett 427: 263-266, 1998.
38. Patel JM, Zhang J, and Block ER. Nitric-oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am J Respir Cell Mol Biol 15: 410-419, 1996.
39. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060, 1998.
40. Posch K, Schmidt K, and Graier WF. Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide. Life Sci 64: 663-670, 1999.
41. Prat AG, Xiao Y-F, Ausiello DA, and Cantiello HF. cAMP-independent regulation of CFTR by actin cytoskeleton. Am J Physiol Cell Physiol 268: C1552-C1561, 1995.
42. Sase K and Michel T. Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med 7: 28-37, 1997.
43. Schmidt K, Werner-Felmayer G, Mayer B, and Werner ER. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin. Eur J Biochem 259: 25-31, 1999.
44. Schott CA, Gray GA, and Stoclet JC. Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br J Pharmacol 108: 38-43, 1993.
45. Sessa WC, Garcia-Cardena G, Liu J, Keh A, Pollock JS, Bradley J, Thiru S, Braverman I, and Desai KM. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem 270: 17641-17644, 1995.
46. Shaul PW and Anderson RGW. Role of plasmalemmal caveolae in signal transduction. Am J Physiol Lung Cell Mol Physiol 275: L843-L851, 1998.
47. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, and Michel T. Acylation targets endothelial nitric oxide synthase to plasmalemmal caveolae. J Biol Chem 271: 6518-6523, 1996.
48. Smart EJ, Ying Y, Mineo C, and Anderson RGW. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92: 10104-10108, 1995.
49. + and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol (Lond) 489: 183-192, 1995.
50. Spector I, Braet F, Shochet NR, and Bubb MR. New antiactin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech 47: 18-37, 1999.
51. Venema VJ, Marrero MB, and Venema RC. Bradykininstimulated protein phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun 226: 703-710, 1996.
52. Wang Q, Patton WF, Chiang ET, Hechtman HB, and Shepro D. Filamin translocation is an early endothelial cell inflammatory response to bradykinin: regulation by calcium, protein kinases and protein phosphatases. J Cell Biochem 62: 383-396, 1996.
53. Wang Q, Patton WF, Hechtman HB, and Shepro D. A novel anti-inflammatory peptide inhibits endothelial cell cytoskeletal rearrangement, nitric oxide synthase translocation, and paracellular permeability increases. J Cell Physiol 172: 171-182, 1997.
54. + (CAT-1) amino acid transporter as detected by immunohistochemistry. Am J Physiol Endocrinol Metab 266: E817-E824, 1994.
55. Wu Z, Wong K, Glogauer M, Ellen RP, and McCulloch CA. Regulation of stretch-regulated intracellular calcium transients by actin filaments. Biochem Biophys Res Commun 261: 419-425, 1999.
56. Zharikov SI and Block ER. Characterization of L-arginine uptake by plasma membrane vesicles isolated from cultured pulmonary artery endothelial cells. Biochim Biophys Acta 1369: 173-183, 1998.
57. Zharikov SI and Block ER. Association of L-arginine transporter with fodrin: implications for hypoxic inhibition of L-arginine uptake. Am J Physiol Lung Cell Mol Physiol 278: L111-L117, 2000.
58. Zharikov SI, Herrera H, and Block ER. Role of membrane potential in hypoxic inhibition of L-arginine uptake by lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 272: L78-L84, 1997.